Daewoong Pharma to Export Drugs to Iraq

By John Lee.

South Korea’s Daewoong Pharmaceutical has signed a US$25-million contract with Ibn Cina Drug Stores to supply six products to Jordan and Iraq.

According to the Korea Herald, the local partner will distribute:

  • Ursa, for liver function improvement;
  • Orlostar, for high blood pressure and hyperlipidemia;
  • Easyef for diabetic foot ulcer;
  • Daewoong pitavastatin calcium tab, for hyperlipidemia;
  • antibiotic Gomcephin; and,
  • vitamin supplement Roman C powder.

The company entered the Middle Eastern market by launching growth hormone booster filler Caretropin in Iran in 2015 and is seeking to extend its market reach in the region.

(Source: Korea Herald)

5 Responses to Daewoong Pharma to Export Drugs to Iraq